HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich
Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in the Fields of Leukemia Research and Molecular Genetics TUCSON, Ariz. , Dec. 16, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its
- Category:
- Press Releases